C12N 2710/16571
Demonstrated in vivo effect
C12N2710/16571 (Demonstrated in vivo effect) appears on 3 US grants and 5 published applications in this corpus.
Search patents in C12N- Granted patents
- 3
- Published applications
- 5
- Assignees
- 2
- Inventors
- 3
- Latest grant
- 7 Jan 2020
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 1 | 2 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 1 | 1 |
By publication year.
Recent patents
- Factor involved in latent infection with herpesvirus, and use thereof7 Jan 2020US 10,526,374 B2Japan Tobacco Inc.
- Factor involved in latent infection with herpes virus, and use thereof26 Nov 2019US 10,487,118 B2Japan Tobacco Inc.
- Diagnosis of mood disorders by detecting latent infection with human herpesvirus-630 Apr 2013US 8,431,352 B2Japan Tobacco Inc.
- Animal model of a mood disorder and screening method5 Mar 2020US 2020/0071363 A1Japan Tobacco Inc.
- Factor involved in latent infection with herpes virus, and use thereof6 Jul 2017US 2017/0190745 A1Japan Tobacco Inc.
- Factor involved in latent infection with herpesvirus, and use thereof22 Aug 2013US 2013/0217044 A1Japan Tobacco Inc.
- Factor involved in latent infection with herpesvirus, and use thereof30 May 2013US 2013/0137088 A1Japan Tobacco Inc.
- Factor involved in latent infection with herpesvirus, and use thereof4 Nov 2010US 2010/0281550 A1Japan Tobacco Inc.
Most cited
By later US patents